WO2013087096A1 - Dispositif de manchon endoluminal et procédés pour déployer un manchon endoluminal dans le tractus gi - Google Patents

Dispositif de manchon endoluminal et procédés pour déployer un manchon endoluminal dans le tractus gi Download PDF

Info

Publication number
WO2013087096A1
WO2013087096A1 PCT/EP2011/072637 EP2011072637W WO2013087096A1 WO 2013087096 A1 WO2013087096 A1 WO 2013087096A1 EP 2011072637 W EP2011072637 W EP 2011072637W WO 2013087096 A1 WO2013087096 A1 WO 2013087096A1
Authority
WO
WIPO (PCT)
Prior art keywords
sleeve
wall
endoluminal
lumen
section
Prior art date
Application number
PCT/EP2011/072637
Other languages
English (en)
Inventor
Mark Steven ZEINER
Mark Steven Ortiz
José M. BERGER
Randy J. Seeley
James W. Voegele
Michael A. Murray
Michele D'arcangelo
Jason Harris
Alessandro Pastorelli
Carrie BENZINGER
David Cagle
Original Assignee
Ethicon Endo-Surgery, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Endo-Surgery, Inc. filed Critical Ethicon Endo-Surgery, Inc.
Priority to PCT/EP2011/072637 priority Critical patent/WO2013087096A1/fr
Publication of WO2013087096A1 publication Critical patent/WO2013087096A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/0076—Implantable devices or invasive measures preventing normal digestion, e.g. Bariatric or gastric sleeves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2002/045—Stomach, intestines

Definitions

  • the present invention relates generally to medical apparatuses and methods and more particularly to devices and methods for positioning a lining to a hollow body organ, such as a stomach, intestine or gastrointestinal tract.
  • endoluminal sleeves are known for partially or totally lining certain portions of the stomach and of the intestine with the aim to separate or bypass at least part of the food flow from the lined portions of the gastrointestinal tract. It has been observed that by creating a physical barrier between the ingested food and certain regions of the gastrointestinal wall by means of endoluminal sleeves, similar benefits for weight loss and improvement or resolution of type 2 diabetes may be achieved as with gastric bypass surgery. Physicians believe that by creating a physical barrier between the ingested food and selected regions of the gastrointestinal wall, it might be possible to purposefully influence the mechanism of hormonal signal activation originating from the intestine. It was observed that endoluminal
  • Endosleeves in certain regions of the stomach and the duodenum contributed to improve glycemic control and to reduce or eliminate other co-morbidities of obesity. Moreover the lining of parts of the Gl-tract by means of endosleeves provide an alternative or an additional therapy to traditional therapies of type II diabetes and obesity. Endosleeves may be placed in a brief and less invasive procedure and address the patient's fear of surgery. Contrary to traditional gastric bypass surgery, the result of endoluminal sleeve surgery is reversible and the sleeve can be removed after achievement of the clinical result, but also in case of the occurrence of undesired side effects or clinical complications.
  • a typical duodenal sleeve device is described in U.S. Pat. No. 7,267,694 where the proximal end of a flexible, floppy sleeve of impermeable material defining a sleeve lumen is endoscopically deployed and anchored with the help of a barbed stent in the pylorus or in the superior section of the duodenum, the stent also ensuring that the proximal lumen opening of the sleeve remains open. Chyme from the stomach enters the proximal lumen opening of the sleeve and passes through the sleeve lumen to the distal lumen opening.
  • Digestive enzymes secreted in the duodenum pass through the duodenum on the outside of the sleeve.
  • the enzymes and the chyme do not mix until the chyme exits from the distal lumen opening of the liner tube. In such a way, the efficiency of the process of digestion of the chyme is diminished, reducing the ability of the gastrointestinal tract to absorb calories from the food.
  • a further important issue with endoluminal sleeves is the risk of failure of sealing of the lined lumen and, hence, the risk of an undesired leakage of the partially digested food flow in the interstice between the lumen wall and the sleeve. Therefore, there is a need for improved sleeve devices and procedures for sealing interstices between the lining and the
  • known sleeve devices effectively address the need of selectively preventing the contact of the food flow with a certain length of Gl tract.
  • the known sleeve devices fail to selectively prevent the contact of the food flow with certain regions of the Gl wall, while allowing the food contact with bordering regions of the Gl wall in the same longitudinal position. Therefore, there is a need for improved sleeve devices and procedures for allowing a selective isolation and contact between the Gl wall and a food flow in multiple regions of the Gl tract.
  • the present invention provides for an endoluminal, particularly duodenal, sleeve device and method for the transoral, or endoscopic, positioning and anchoring of an endoluminal sleeve device within a gastrointestinal tract, including, but not limited to, the pylorus, the esophagus, stomach, duodenum as well as other portions of or the entire length of the intestinal tract, etc., unless specified otherwise.
  • the surgeon or endoscopist may insert devices as described below through the patient's mouth, down the esophagus and into the stomach or intestine as appropriate. The procedure can be performed entirely from within the patient's stomach or other intestinal tract, and does not necessarily require any external incision. Alternatively, the surgeon may insert devices as described below laparoscopically into the stomach or intestine as appropriate.
  • an endoluminal sleeve device comprising:
  • a sleeve configured for deployment inside an intestine of a human subject, the sleeve having a wall of a flexible material, the wall defining a sleeve lumen and having:
  • compacting means attached to the wall, said compacting means constraining the wall in a transversally folded shape which narrows the cross section along a prevalent portion of
  • a sleeve configured for deployment inside an intestine of a human subject, the sleeve having a wall of a flexible material, the wall defining a sleeve lumen and having: a longitudinal extension from a proximal end forming a proximal lumen opening to a distal end forming a distal lumen opening, and
  • the sleeve By reducing the transverse dimensions of the sleeve to a value which is significantly smaller than the diameter of the involved section of intestine during insertion and full longitudinal deployment, the sleeve can more easily advance through the winding path of the intestine and worm its way through sections of intestine which are partially obstructed by residual intestinal contents. This reduces the risk that the sleeve may jib and fold over while it is unfolded und pushed along the intestine. After complete longitudinal deployment of the sleeve, it is then unfolded transversally to gain an expanded cross-section which may match the internal diameter of the intestine or somewhat expand it beyond the physiological dimensions to accommodate the chyme flow and avoid restriction.
  • an endoluminal sleeve device comprising:
  • a sleeve configured for deployment inside an intestine of a human subject, the sleeve having a wall of a flexible material, the wall defining a sleeve lumen, a proximal end forming a proximal lumen opening and a distal end forming a distal lumen opening, and
  • END6979 a sleeve sealing portion connected to the wall, said sealing portion having a tubular expansion portion permanently elastically biased in a radially expanded shape, and an annular sealing lip formed at a proximal end of the expansion portion and protruding radially outward from the expansion portion, thereby forming an annular sealing line.
  • the sealing lip is configured to prevent a pull resistant anchoring contact between the expansion portion and surrounding tissue, thereby providing a floating or sliding sleeve sealing portion adapted to slide inside an intestine.
  • the sealing lip is made of a soft and pliable elastomeric material and bendable both in a proximal and a distal direction to allow non traumatic sliding of the sleeve sealing portion within an intestine both in a distal and proximal direction.
  • an endoluminal sleeve device comprising:
  • a sleeve configured for deployment inside an intestine of a human subject, the sleeve having a wall of a flexible material, the wall defining a sleeve lumen, a proximal end forming a proximal lumen opening and a distal end forming a distal lumen opening, at least one leak opening formed in said wall remote from the proximal and distal ends, and
  • tissue anchoring portion connected with said wall near said leak opening, said tissue anchoring portion being adapted to securing the wall with the leak opening to a target tissue of intestine for a planned contact between a flow of contents inside the sleeve lumen and said target tissue.
  • a sleeve configured for deployment inside an intestine of a human subject, the sleeve having a wall of a flexible material, the wall defining a sleeve lumen, a proximal end forming a proximal lumen opening and a distal end forming a distal lumen opening, and at least one leak opening formed in said wall remote from the proximal and distal ends;
  • END6979 securing the wall with the leak opening directly to the target tissue of intestine for a contact between a flow of contents inside the sleeve lumen and said target tissue.
  • an endoluminal sleeve device comprising:
  • a sleeve configured for deployment inside an intestine of a human subject, the sleeve having a wall of a flexible material, the wall defining a sleeve lumen, a proximal end forming a proximal lumen opening and a distal end forming a distal lumen opening, anti backflow means provided at the wall near the proximal lumen opening and configured to partially obstruct a proximal backflow of contents from inside the sleeve lumen towards the proximal lumen opening.
  • the sleeve can be e.g. anchored at or below the Cardia of a stomach and prevent upward reflux under normal conditions.
  • Figures 1 through 3 illustrate a method and device for internally lining a section of a Gl tract in accordance with an embodiment
  • Figures 4 through 7 illustrate embodiments of duodenal sleeve devices adapted to implement the method of figures 1 to 3;
  • Figure 8A illustrates a sleeve wall in a transversally folded shape with reduced cross section of the sleeve wall, in accordance with an embodiment
  • Figure 8B illustrates the sleeve wall of figure 8A in a transversally unfolded shape
  • Figure 9A illustrates a sleeve wall in a transversally folded shape with reduced cross section of the sleeve wall, in accordance with a further embodiment
  • Figure 9B illustrates the sleeve wall of figure 8A in a transversally unfolded shape with an increased cross section of the sleeve wall
  • Figures 10A and 10B illustrate method steps and devices for internally lining a section of intestine in accordance with a further embodiment
  • Figures 10C and 10D illustrate method steps and devices for internally lining a section of intestine in accordance with a further embodiment
  • Figures 1 1 through 16 illustrate sealing portions of an endoluminal sleeve in accordance with embodiments of the invention
  • Figures 17 through 20 illustrate expansion tube inserts of sealing portions for an endoluminal sleeve in accordance with embodiments of the invention
  • Figure 21 shows a longitudinal cross-section of a duodenal sleeve with an intermediate sealing and bile capture portion in accordance with an embodiment of the invention
  • Figure 22 is a cross-sectional view according to a sectional plane XXII in figure 21 ;
  • Figure 23 illustrates a duodenal sleeve with an intermediate sealing and bile capture portion in accordance with a further embodiment of the invention
  • Figure 24 illustrates an endoluminal sleeve in accordance with a further embodiment
  • Figure 25 shows a longitudinal cross-section of the sleeve of figure 24 anchored in a section of a Gl tract
  • Figure 26 shows a portion of an internal surface of an endoluminal sleeve in accordance with an embodiment
  • Figure 27 shows a method and devices for internally lining a section of a Gl tract and planned contact of food flow with a selected target tissue of a gastric wall
  • Figure 28 shows a method and devices for internally lining a section of a Gl tract and planned contact of food flow with a selected target tissue at the proximal duodenum;
  • Figure 29 is a cross-sectional view of a portion of an endoluminal sleeve having leak openings in accordance with an embodiment
  • Figure 30 is a cross-sectional view of a portion of an endoluminal sleeve having leak openings in accordance with a further embodiment.
  • END6979 sleeve device 1 for internally lining a section of the Gl tract, particularly a section of duodenum distally from the pylorus or a gastro-intestinal section below the Cardia, comprises a sleeve 2 configured for deployment inside an intestine of a human subject, the sleeve 2 having a wall 8 of a flexible material defining a sleeve lumen 3, a proximal end 4 defining a proximal lumen opening 5, and a distal end 6 defining a distal lumen opening 7, a longitudinal extension from the proximal end 4 to the distal end 6 and a transverse extension defining a cross section of the sleeve 2.
  • the sleeve device 1 further comprises compacting means attached to the wall 8 and constraining the wall 8 in a transversally folded shape (Figures 1 and 2) which narrows the cross section along a prevalent portion of the longitudinal extension of the wall 8 during a longitudinally unfolding of the wall 8 to its full longitudinal extension ( Figure 2).
  • the compacting means can be released when the wall 8 is longitudinally unfolded (Figure 2), thereby allowing the wall 8 to transversally unfold to an expanded cross section (Figure 3).
  • the sleeve 2 can more easily advance through the winding path of the intestine and find its way through sections of intestine which are partially obstructed by residual intestinal contents. This reduces the risk that the sleeve may jib and fold over while it is unfolded und pushed along the intestine. After complete longitudinal deployment of the sleeve 2, it is then unfolded transversally to gain an expanded cross-section which may match the internal diameter of the intestine 9 or somewhat expand it beyond the physiological dimensions to accommodate the chyme flow and avoid restriction.
  • the sleeve wall 8 comprises a plurality of longitudinally extending folds 10 secured along their length by a suture 1 1 which can be pulled out of the wall 8 or dissolved or loosened (by releasing its tension) after the sleeve wall 8 has been fully longitudinally deployed and unfolded, thereby allowing the longitudinal folds 10 to unfold and straighten transversally.
  • the sleeve wall 8 comprises a plurality of longitudinally extending folds 10 secured along their length and tightened to one another by a suture 1 1 which can be pulled out of the wall 8 or dissolved or loosened (by releasing its tension) after the sleeve wall 8 has been fully longitudinally deployed and unfolded.
  • the longitudinal folds 10 can define one or more inextensible inflatable channels 12 ( Figure 6) which have a preferably significantly reduced section with respect to the expanded cross-section of the sleeve 2. This makes it possible to longitudinally deploy the sleeve 2 by inflation of the inflatable channel 12 without expanding the entire sleeve lumen and, hence, without obstructing the intestine with a fully inflated sleeve.
  • the longitudinal folds 10 are preferably configured such that, after removal of the suture 1 1 , the inflatable channel or channels 12 become part of the internal sleeve lumen 3. In this manner, after completion of the longitudinal deployment of the sleeve 2 and removal of the suture 1 1 , the sleeve 2 can be transversally unfolded by simply further inflating the sleeve lumen 3.
  • the above described longitudinal folds are secured and, if provided, connected to one another by means of a dissolvable glue which can be provided instead of the suture 1 1 or in addition to the suture 1 1 .
  • two facing (external or internal) wall 8 surfaces of at least one of the longitudinal folds 10 are glued together to form a non inflatable region of the sleeve 2, thereby reducing the transverse section of the inflated sleeve during longitudinal deployment.
  • the glue can be dissolved after full longitudinal deployment of the sleeve 2, e.g. by exposure of an external fold (Figures 9A, 9B) to the humid intestinal wall or by filling the sleeve lumen 3 with a solvent agent, e.g. water or saline solution, adapted to removes the glue from an internal fold ( Figures 8A, 8B).
  • a solvent agent e.g. water or saline solution
  • the above described longitudinal folds are secured and possibly connected to one another by means of a removable adhesive tape 13 (dashed line in figure 9A) which can be provided instead or in addition to the suture 1 1 and or to the directly applied glue.
  • the adhesive tape 13 additionally seals and reinforces the longitudinal folds 10.
  • the compacting means includes a removable, e.g. dissolvable, auxiliary tube 14 extended along a prevalent portion of the length of the sleeve 2 and adapted to constrain the wall 8 in the transversally folded shape during longitudinal deployment thereof.
  • a removable, e.g. dissolvable, auxiliary tube 14 extended along a prevalent portion of the length of the sleeve 2 and adapted to constrain the wall 8 in the transversally folded shape during longitudinal deployment thereof.
  • FIGS 10A and 10B illustrate an auxiliary tube 14 arranged inside the sleeve lumen 3 and having a diameter which is significantly smaller than the diameter of the sleeve lumen 3.
  • the auxiliary tube 14 defining an internal suction and inflation channel 15 to which a pump 18 can be connected to inject or remove air or other fluid.
  • END6979 and inflation channel 15 comprises a plurality of lateral openings 16 distributed along the length of the sleeve wall 8 and adapted to constrain the wall 8 in the transversally folded shape by suction and to unfold the wall 8 transversally by inflation.
  • the auxiliary tube 14 may be dissolved or otherwise removed from the sleeve 2.
  • the auxiliary tube 14 is inserted externally over the transversally folded sleeve wall 8 and adapted to constrain the sleeve wall 8 in the reduced cross section configuration during insertion and longitudinal deployment of the sleeve wall.
  • the auxiliary tube 14 may be dissolved or otherwise removed from the sleeve 2, thereby allowing the sleeve wall 8 to unfold transversally to its expanded cross- section.
  • the auxiliary tube 14 may have a greater stiffness than the sleeve 2 in order to stiffen the sleeve 2 while it is advanced, e.g. pushed, distally in the Gl tract.
  • the auxiliary tube 14 may have an atraumatic rounded distal tip 17 protruding distally beyond the distal end 6 of the sleeve 2.
  • the above described sleeve device 1 can be advantageously used during a method for endoluminally lining a section of a Gl tract, in which, prior to the insertion of the sleeve 2, the wall 8 is compacted and constrained in a transversally folded shape which narrows the cross section along a prevalent portion of the longitudinal extension of the wall 8. Then, the sleeve 2 is inserted in a target section of the Gl tract and the wall 8 is longitudinally unfolded to its full longitudinal extension while maintaining the wall 8 in the transversally folded shape. Only after the wall 8 has been longitudinally unfolded, it is released from the transversally folded shape such that it can transversally unfold to an expanded cross section.
  • the step of transversally compacting the sleeve wall 8 comprises creating at least one longitudinal fold 10 in the sleeve wall 8 along a substantial part of the length of the sleeve 2 and securing the longitudinal fold 10 by a suture 1 1 , by gluing or by an adhesive tape 13.
  • the step of transversally compacting the sleeve wall 8 comprises creating a plurality of at least two longitudinal folds 10 in the sleeve wall 8 along a substantial part of the length of the sleeve 2 and securing each longitudinal fold 10 separately by an individual suture 1 1 , gluing or by an individual
  • the step of transversally compacting the sleeve wall 8 comprises creating a plurality of at least two longitudinal folds 10 in the sleeve wall 8 along a substantial part of the length of the sleeve 2 and connecting the longitudinal folds 10 to each other by means of suturing, by gluing or by an adhesive tape 13.
  • the step of transversally compacting the sleeve wall 8 comprises applying suction to the sleeve lumen 3 or inserting the sleeve 2 inside an auxiliary tube 14 having a smaller diameter than the transversally unfolded sleeve 2.
  • the step of releasing the wall 8 may comprise one or more of dissolving the suture 1 1 , pulling the suture out of the wall 8, releasing the tension of the suture, but leaving the suture in place (for a future transverse folding and compacting of the sleeve wall 8), dissolving the glue, dissolving the adhesive tape 13, removing the adhesive tape 13 by pulling it away from the wall 8, dissolving or otherwise removing the auxiliary tube 14 from the sleeve wall 8.
  • the step of deploying the sleeve 2 longitudinally comprises forming an inflatable channel 12 by means of the longitudinal folds 10 such that the inflatable channel 12 has a cross section smaller than a cross- section of the transversally unfolded sleeve lumen 3, and inflating the inflatable channel 12.
  • the method may further comprise the step of compacting the sleeve 2 longitudinally, e.g. by folding the sleeve, rolling the sleeve up or by accordion-like folding the sleeve, before inserting the sleeve 2 in the Gl tract.
  • the method may comprise the step of expanding the sleeve 2 transversally from the transversally folded shape to a transversally unfolded shape, e.g. by inflating the sleeve lumen 2.
  • the transversally folded shape of the sleeve wall 8 may have a cross-sectional width (i.e. diameter in case of an approximately circular shape) of between 1 /2 and 1/5, preferably of less than 1/3 of the transversally unfolded cross-sectional width of the sleeve 2.
  • an endoluminal sleeve device 1 comprising a sleeve 2 configured for deployment inside an intestine 9 of a human subject, the sleeve 2 having a
  • the device 1 further comprises a sleeve sealing portion 19 connected to the wall 8 and having a tubular expansion portion 20 permanently elastically biased in a radially expanded shape, and an annular sealing lip 21 formed at a proximal end of the expansion portion 20 and protruding radially outward from the expansion portion 20.
  • the expansion portion 20 presses the sealing lip 21 radially against the surrounding tissue, thereby establishing an annular sealing line between the sealing lip 21 and the tissue.
  • the sealing lip 21 pushes the surrounding tissue locally radially away from the tubular expansion portion 20 or at least decreases a contact pressure between the tissue and the tubular expansion portion 20.
  • This particular configuration of the sealing lip 21 prevents a pull resistant anchoring contact between the expansion portion 20 and a surrounding tissue, thereby providing a floating or sliding sleeve seal which allows the sealing portion to slide inside an intestine.
  • a floating seal configuration reduces the local stress applied to the tissue of the Gl tract at the sealing portion 19 and assures a reliable leak prevention also during and after dislocations of the sleeve 2 inside a Gl tract.
  • the sealing lip 21 is made of a soft and pliable elastomeric material and bendable with respect to the tubular expansion portion 20 both in a proximal and a distal direction to allow non traumatic sliding of the sleeve sealing portion 19 within an intestine both in a distal and proximal direction.
  • the sleeve device 1 may additionally comprise an anchoring portion 22 (dashed line in figure 15) connected e.g. by means of a tether 43 with the sleeve wall 8 or the sealing portion 19 and adapted to anchor the sleeve 2 inside a target section of the Gl tract without necessarily accomplishing a sealing function.
  • an anchoring portion 22 dashed line in figure 15
  • the sealing portion 19 may be arranged at the proximal sleeve end 4 and can be e.g. positioned distal of the pylorus, while the anchoring portion 22 can be placed inside the stomach.
  • the sealing lip can have a shape, e.g. a proximally widening funnel shape (compare figures 1 1 , 12, 13 and 15), which widens radially during distal flexure and narrows radially during proximal flexure with respect to the tubular expansion portion 20, so that a proximal retrograde motion of the sealing portion 19 inside the intestine is at least somewhat hindered, while a distal motion thereof is allowed to occur more easily.
  • a proximally widening funnel shape (compare figures 1 1 , 12, 13 and 15)
  • the sealing lip 21 has undulations in an axial (or longitudinal) direction 23 of the sealing portion 19 and an external surface with a continuous convex shape, thereby preventing the formation of concavities in a radial direction 24 which might lead to undesired leakage between the sleeve and the Gl wall.
  • the tubular expansion portion 20 comprises an undulated or zigzag shaped wall which adapts to a large range of diameters of intestinal wall and which can be easily transversally compacted during placement.
  • the tubular expansion portion 20 comprises a helix shaped expansion and sealing rip 24 formed on an external surface 25 of the expansion portion 20 and which is adapted to bias the expansion portion 20 permanently radially outward and to engage a surrounding tissue along an additional helix shaped sealing line.
  • the tubular expansion portion 20 comprises a net of interconnected expansion and sealing rips 26 formed on the external surface 25 of the expansion portion 20 and adapted for a tight engagement of surrounding tissue.
  • Figures 17 through 19 illustrate possible embodiments of inserts 44 which may be incorporated in the tubular expansion portion 20 in order to permanently bias it outward.
  • the inserts 44 may comprise multiple interconnected undulated rings ( Figures 17, 18), multiple interconnected plane rings (figure 19) or an elastic tube with a plurality of weakening holes (figure 20).
  • the tubular expansion portion of the sleeve sealing portion 19 defines an internal surface 28 in communication with a secondary sleeve lumen 27 (e.g. formed by an additional sleeve wall 29 which may extend parallel to or be coaxially arranged about the sleeve wall 8) adapted to drain digestive secretions such as for example biliopancreatic juices.
  • a secondary sleeve lumen 27 e.g. formed by an additional sleeve wall 29 which may extend parallel to or be coaxially arranged about the sleeve wall
  • the sealing portion 19 may comprise a semi-rigid or rigid connecting ring 30 or tube arranged radially inside the tubular expansion portion 20 and connected to the tubular expansion portion 20 by at least one, preferably at least two collapsible arms 31 adapted to allow a radial deformation of the tubular expansion portion 20 without deforming the connecting ring 30.
  • This makes it possible to adapt the sealing portion 19 to different intestinal lumen dimensions and to accommodate peristalsis without interfering with the diameter of the sleeve lumen 3.
  • sealing portion 19 may be arranged distally of a sphincter of ODDI in order to provide a seal against leakage of biliopancreatic secretions between the sleeve device 1 and the duodenal wall and with the additional purpose of selectively draining the biliopancreatic secretions separate from both the intestinal wall and, possibly, of selectively preventing and/or promoting a contact between a chyme flow inside the sleeve lumen 3 and the captured biliary fluid.
  • the collapsible arms 31 are inclined with respect to a longitudinal axis 32 of the sealing portion 19 such that a radial deformation of the expansion portion 20 brings about a (substantially cantilever type) flexure of the collapsible arms 31 which doesn't generate substantial compression in a local longitudinal direction of the arms 31 .
  • Such a flexure of the collapsible arms 31 may be further improved by forming flexure hinges 33 at both ends of the arms 31 .
  • an endoluminal sleeve device 1 comprising a sleeve 2 configured for deployment inside an intestine 9 of a human subject, the sleeve 2 having a wall 8 of a flexible material, the wall 8 defining a sleeve lumen 3, a proximal end 4 forming a proximal lumen opening 5 and a distal end 6 forming a distal lumen opening 7.
  • the sleeve device 1 further includes at least one leak opening 34 formed in the wall 8 remote from the proximal and distal ends 4, 6, and a tissue anchoring portion 35 connected with the wall 8 near said leak opening 34.
  • the tissue anchoring portion 35 may include:
  • the tissue anchoring portion 35 is adapted to fasten the wall 8 near the leak opening 34 to a target tissue of intestine for a selective contact between a flow of contents inside the sleeve lumen 3 and the target tissue.
  • the leak openings 34 formed in the wall 8 of the sleeve allow a contact between chyme flow and Gl wall tissue in selected positions along a circumference of a target section of Gl tract, e.g. in one or more specific regions of the stomach (Figure 27) or of the proximal duodenum (Figure 28).
  • the tissue anchoring portion 35 is arranged within a distance of less than 5 cm, preferably less than 2 cm from the leak opening 34.
  • the leak opening 34 comprises a selectively permeable shield 36 adapted to allow the passage of only one or more predetermined nutrients, e.g. fats, through the leak openings 34.
  • the leak openings 34 may have an adjustable size, e.g. thanks to a shield member 37 slidably connected to the sleeve wall 8 and adapted to adjustably overlap the leak openings 34 ( Figures 29, 30).
  • an endoluminal sleeve device 1 comprising a sleeve 2 configured for deployment inside an intestine 9 of a human subject, the sleeve 2 having a wall 8 of a flexible material, the wall 8 defining a sleeve lumen 3, a proximal end 4 forming a proximal lumen opening 5 and a distal end 6 forming a distal lumen opening 7.
  • the device 1 further comprises anti backflow means 39 provided at the wall 8 near the proximal lumen opening 5 and configured to partially obstruct a proximal backflow of contents from inside the sleeve lumen 3 towards the proximal lumen opening 5.
  • anti backflow means 39 provided at the wall 8 near the proximal lumen opening 5 and configured to partially obstruct a proximal backflow of contents from inside the sleeve lumen 3 towards the proximal lumen opening 5.
  • the sleeve 2 can be e.g. anchored at or below the Cardia of a stomach and will prevent upward reflux under normal conditions.
  • the anti backflow means 39 can comprise a one way valve, e.g. a flapper valve 40, which allows a passage of contents in a distal direction (i.e. introduction of food into the proximal lumen opening 5), but prevents a proximal backflow of contents.
  • a flapper valve 40 which allows a passage of contents in a distal direction (i.e. introduction of food into the proximal lumen opening 5), but prevents a proximal backflow of contents.
  • the anti backflow means 39 can be embodied by a stepped internal surface 41 of the sleeve wall 8, said stepped surface 41 having a plurality of circumferentially extending distally facing risers 42 adapted to slow down and lessen an undesired proximal reflux inside the sleeve 2.
  • the sleeve 2 itself is sufficiently flexible to follow the curvature of the duodenum. Further, in some embodiments the walls of the sleeve are sufficiently flexible and/or
  • END6979 collapsible to allow duodenal peristalsis to drive chyme through the lumen of the sleeve.
  • Sufficient collapsibility of the walls of the sleeve prevents continuous intimate contact of the outer surface of the sleeve with the duodenal mucosa, avoiding damage to the duodenal mucosa and allowing digestive secretions not collected into the sleeve lumen to pass through the duodenal lumen outside the sleeve lumen.
  • the diameter of the sleeve lumen may be substantially constant along the entire length of the liner tube.
  • the luminal diameter may be not more than about 30 mm, not more than about 25 mm and even not more than about 20 mm.
  • the proximal end of the sleeve may be flared and may define a funnel-like structure.
  • the length of the sleeve may be any suitable length and may be selected in accordance with clinical decisions made by the treating physician.
  • a typical sleeve is between about 25 cm and about 160 cm long.
  • the sleeve is selected so that when the duodenal sleeve device is deployed, the distal lumen opening of the sleeve is located distal to the duodenal-jejunal flexure and empties out into the jejunum. In some embodiments, the sleeve may be even longer.
  • Suitable materials from which the sleeve for implementing the invention are fashioned include silicone, polyurethane, polyethylene (e.g., low density polyethylene films) and fluoropolymers (e.g., expanded polytetrafluoroethylene).
  • the sleeve is fashioned from fluoropolymer or polyethylene film impregnated with polyurethane or silicone to reduce permeability, as taught in U.S. Pat. No. 7,267,694.
  • the sleeve may include one or more markers (e.g., barium) designed for viewing the position of the sleeve within the intestines through fluoroscopy, such as a longitudinal rib or other markers that are spaced along the length of sleeve.
  • markers e.g., barium
  • sleeve may further include components that inhibit twisting or kinking of the sleeve itself.
  • these components include one or more stiffening elements, such as rings, coupled to either the inside or the outside of the sleeve at spaced locations along its length. These rings can, for example, be made of a slightly thicker silicone material that would resist twisting or kinking of the sleeve around the ring.
  • the stiffening elements may be in spiral shape or extending lengthwise along at least a portion of the sleeve.
  • the sleeve may be initially folded or rolled up and packed into the interior of an applier.
  • the distal end of sleeve may be initially closed, e.g.
  • END6979 with a small polymeric or silicone seal and forms a programmed tearing line, e.g. a perforation, along which the distal end can tear open by the internal pressure of the chyme flow.
  • a programmed tearing line e.g. a perforation
  • bypass conduits can be created in the Gl tract of a patient to achieve a malabsorptive effect in cases where such an effect may enhance weight loss, as well as the initially described effects on hormonal signaling in general.

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Prostheses (AREA)
  • Obesity (AREA)
  • Nursing (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Child & Adolescent Psychology (AREA)

Abstract

La présente invention concerne un dispositif de manchon endoluminal (1) pour le revêtement interne d'une section du tractus gastro-intestinal, qui comprend un manchon (2) ayant une extension longitudinale et une extension transversale définissant une section transversale du manchon (2), des moyens de compactage reliés au manchon (2) et la contrainte d'une paroi (8) du manchon dans une forme transversalement pliée qui rétrécit la section transversale de la paroi (8) le long d'une partie prévalente de l'extension longitudinale pendant le déploiement longitudinal de la paroi (8) à son extension longitudinale totale, les moyens de compactage pouvant être libérés lorsque la paroi (8) est longitudinalement dépliée, permettant ainsi à la paroi (8) de se déplier transversalement depuis ladite section transversale rétrécie jusqu'à une section transversale déployée.
PCT/EP2011/072637 2011-12-13 2011-12-13 Dispositif de manchon endoluminal et procédés pour déployer un manchon endoluminal dans le tractus gi WO2013087096A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/072637 WO2013087096A1 (fr) 2011-12-13 2011-12-13 Dispositif de manchon endoluminal et procédés pour déployer un manchon endoluminal dans le tractus gi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/072637 WO2013087096A1 (fr) 2011-12-13 2011-12-13 Dispositif de manchon endoluminal et procédés pour déployer un manchon endoluminal dans le tractus gi

Publications (1)

Publication Number Publication Date
WO2013087096A1 true WO2013087096A1 (fr) 2013-06-20

Family

ID=45315831

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/072637 WO2013087096A1 (fr) 2011-12-13 2011-12-13 Dispositif de manchon endoluminal et procédés pour déployer un manchon endoluminal dans le tractus gi

Country Status (1)

Country Link
WO (1) WO2013087096A1 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015198936A (ja) * 2014-04-05 2015-11-12 レックス メディカル リミテッド パートナーシップ 肥満を治療するための十二指腸スリーブ
EP2604223B1 (fr) * 2011-12-15 2016-06-29 Cook Medical Technologies LLC Prothèse antifuite
US9456917B2 (en) 2013-08-28 2016-10-04 Ethicon Endo-Surgery, Inc. Endoscopic transoral duodenal sleeve applier
EP3054860A4 (fr) * 2013-10-10 2017-08-23 Nitinotes Ltd. Gastroplastie par manchon endoluminal
US10350099B2 (en) 2006-09-01 2019-07-16 Ethicon Endo-Surgery, Inc. Devices and methods for anchoring an endoluminal sleeve in the GI tract
US10779979B2 (en) 2013-10-10 2020-09-22 Nitinotes Ltd. Endoluminal sleeve gastroplasty
US11406522B2 (en) 2016-11-09 2022-08-09 Boston Scientific Scimed, Inc. Deployable sleeves and related methods

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040804A1 (en) * 2001-08-27 2003-02-27 Stack Richard S. Satiation devices and methods
WO2004080336A2 (fr) * 2003-03-12 2004-09-23 Synecor, Llc Procede et dispositif permettant de modifier l'orifice de sortie d'une poche de satiete
US20050085923A1 (en) * 2002-12-02 2005-04-21 Gi Dynamics, Inc. Anti-obesity devices
US7267694B2 (en) 2002-12-02 2007-09-11 Gi Dynamics, Inc. Bariatric sleeve
WO2008030403A1 (fr) * 2006-09-02 2008-03-13 Synecor, Llc Manchons intestinaux et systèmes et procédés de déploiement associés
US20100256775A1 (en) * 2009-04-03 2010-10-07 Metamodix, Inc. Modular gastrointestinal prostheses
WO2010128495A1 (fr) * 2009-05-07 2010-11-11 Rainbow Medical Ltd. Pilule duodénale à rétention gastrique
US20110004228A1 (en) * 2009-07-01 2011-01-06 E2 Llc Systems and Methods for Treating Obesity and Type 2 Diabetes
WO2011073970A1 (fr) * 2009-12-18 2011-06-23 Vysera Biomedical Limited Dispositif d'implant gastro-intestinal

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040804A1 (en) * 2001-08-27 2003-02-27 Stack Richard S. Satiation devices and methods
US20050085923A1 (en) * 2002-12-02 2005-04-21 Gi Dynamics, Inc. Anti-obesity devices
US7267694B2 (en) 2002-12-02 2007-09-11 Gi Dynamics, Inc. Bariatric sleeve
WO2004080336A2 (fr) * 2003-03-12 2004-09-23 Synecor, Llc Procede et dispositif permettant de modifier l'orifice de sortie d'une poche de satiete
WO2008030403A1 (fr) * 2006-09-02 2008-03-13 Synecor, Llc Manchons intestinaux et systèmes et procédés de déploiement associés
US20100256775A1 (en) * 2009-04-03 2010-10-07 Metamodix, Inc. Modular gastrointestinal prostheses
WO2010128495A1 (fr) * 2009-05-07 2010-11-11 Rainbow Medical Ltd. Pilule duodénale à rétention gastrique
US20110004228A1 (en) * 2009-07-01 2011-01-06 E2 Llc Systems and Methods for Treating Obesity and Type 2 Diabetes
WO2011073970A1 (fr) * 2009-12-18 2011-06-23 Vysera Biomedical Limited Dispositif d'implant gastro-intestinal

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10350099B2 (en) 2006-09-01 2019-07-16 Ethicon Endo-Surgery, Inc. Devices and methods for anchoring an endoluminal sleeve in the GI tract
EP2604223B1 (fr) * 2011-12-15 2016-06-29 Cook Medical Technologies LLC Prothèse antifuite
US10092388B2 (en) 2011-12-15 2018-10-09 Cook Medical Technologies Llc Anti-leakage prosthesis
US9456917B2 (en) 2013-08-28 2016-10-04 Ethicon Endo-Surgery, Inc. Endoscopic transoral duodenal sleeve applier
US10307280B2 (en) 2013-08-28 2019-06-04 Ethicon Endo-Surgery, Inc. Endoscopic transoral duodenal sleeve applier
EP3054860A4 (fr) * 2013-10-10 2017-08-23 Nitinotes Ltd. Gastroplastie par manchon endoluminal
US10433998B2 (en) 2013-10-10 2019-10-08 Nitinotes Ltd. Endoluminal sleeve gastroplasty
US10779979B2 (en) 2013-10-10 2020-09-22 Nitinotes Ltd. Endoluminal sleeve gastroplasty
US11559300B2 (en) 2013-10-10 2023-01-24 Nitinotes Ltd. Endoluminal sleeve gastroplasty
US11690745B2 (en) 2013-10-10 2023-07-04 Nitinotes Ltd. Endoluminal sleeve gastroplasty
JP2015198936A (ja) * 2014-04-05 2015-11-12 レックス メディカル リミテッド パートナーシップ 肥満を治療するための十二指腸スリーブ
US11406522B2 (en) 2016-11-09 2022-08-09 Boston Scientific Scimed, Inc. Deployable sleeves and related methods

Similar Documents

Publication Publication Date Title
US20240164886A1 (en) Methods and devices for anchoring a gastroenterologic sleeve
EP2561839B1 (fr) Dispositif pour ancrer un manchon endoluminal dans l'appareil gastro-intestinal
US7794447B2 (en) Gastrointestinal sleeve device and methods for treatment of morbid obesity
US20180228632A1 (en) Devices and Methods for Anchoring an Endoluminal Sleeve in the GI Tract
US8114045B2 (en) Apparatus and methods for delaying gastric emptying to treat obesity
US8372158B2 (en) Obesity treatment and device
JP2013532013A (ja) 一時的な胃腸保護装置
WO2013087096A1 (fr) Dispositif de manchon endoluminal et procédés pour déployer un manchon endoluminal dans le tractus gi
WO2013023675A1 (fr) Dispositifs pour ancrage de manchon endoluminal dans le tractus gastro-intestinal
US20120245504A1 (en) Devices and methods to deliver, retain and remove a separating device in an intussuscepted hollow organ
WO2013026474A1 (fr) Dispositifs et procédés d'ancrage d'un manchon endoluminal dans le tractus gastro-intestinal
EP2561840B1 (fr) Dispositif pour ancrer un manchon endoluminal dans l'appareil gastro-intestinal
WO2012007044A1 (fr) Dispositif destiné à un détournement transluminal de la bile
WO2012072138A1 (fr) Applicateur et procédé d'ancrage d'un revêtement intérieur à un organe creux
US9265640B2 (en) Conforming anchor for duodenal barrier
WO2013026473A1 (fr) Dispositifs et procédés d'ancrage d'un manchon endoluminal dans le tractus gastro-intestinal
US20120143348A1 (en) Endoluminal lining and a method for endoluminally lining a hollow organ
US20180214292A1 (en) Intragastric device, comprising a rounded element at a distal end and an EXPANDABLE duodenal anchor, and methods of using the same
WO2013023676A1 (fr) Dispositif pour ancrer dans le tube digestif un manchon endoluminal
WO2013023679A1 (fr) Système laparoscopique pour l'ancrage d'un manchon endoluminal dans le tube digestif
WO2013185830A1 (fr) Dispositifs et procédés d'ancrage d'un manchon endoluminal dans le tractus gastro-intestinal
WO2012072137A1 (fr) Système de revêtement intérieur endoluminal et procédé de revêtement intérieur endoluminal d'un organe creux
EP4062879A1 (fr) Tube gastro-intestinal et son ancrage
US20220125434A1 (en) Single anastomosis gastrointestinal tract bypass endoscopic systems and methods
WO2013004267A1 (fr) Cathéter, en particulier destiné à diriger des sécrétions biliopancréatiques

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11794189

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11794189

Country of ref document: EP

Kind code of ref document: A1